...
首页> 外文期刊>International Journal of Pharmaceutics >Microcrystallization of indomethacin using a pH-shift method.
【24h】

Microcrystallization of indomethacin using a pH-shift method.

机译:使用pH位移法对吲哚美辛进行微晶化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study developed a microcrystallization process for indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), using a pH-shift method in aqueous solution. The physicochemical properties of the microcrystals produced were similar to those of the standard crystalline powder in X-ray diffraction (XRD), differential scanning calorimetry (DSC), and Fourier transform infrared spectroscopy (FT-IR) analyses, except for a lower XRD peak height and a slightly lower melting temperature (Tm) (1.5 degrees C). Phase contrast microscopy and scanning electron microscopy (SEM) showed that the indomethacin microcrystals were plate-like with a uniform size distribution (mean diameter =10.4+/-0.4 microm). In the initial phase, the dissolution rate of the indomethacin microcrystals was about 2.2 times higher than that of the standard crystalline powder. The biological activity of the indomethacin microcrystals was about 20% higher than that of the standard crystalline powder in their ability to inhibit the proliferation of colon cancer cells (HT-29).
机译:这项研究开发了一种吲哚美辛(一种非甾体类抗炎药,NSAID)的微晶化工艺,该工艺采用水溶液中的pH值转换法。在X射线衍射(XRD),差示扫描量热法(DSC)和傅里叶变换红外光谱(FT-IR)分析中,所产生的微晶的理化性质与标准晶体粉末的相近,只是XRD峰较低高度和稍低的熔化温度(Tm)(1.5摄氏度)。相差显微镜和扫描电子显微镜(SEM)显示消炎痛微晶为板状,具有均匀的尺寸分布(平均直径= 10.4 +/-0.4μm)。在初始阶段,消炎痛微晶的溶解速率比标准结晶粉末高约2.2倍。吲哚美辛微晶的生物活性比标准结晶粉末高约20%,具有抑制结肠癌细胞(HT-29)增殖的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号